Abrofast-M Tablet PR

Overview Abrofast-M Tablet PR

Respirolin PR tablets are indicated for the management and prophylaxis of asthma and chronic obstructive pulmonary disease (COPD). This medication facilitates easier breathing by relaxing the airway muscles. It's also employed in the treatment of bronchitis. Respirolin PR is administered with or without food, following the dosage and duration prescribed by your physician. Dosage is tailored to individual needs and response. Continuous use, as directed, is crucial; premature cessation may lead to symptom recurrence and disease exacerbation. Inform your healthcare provider of all concurrent medications, as interactions are possible. Common adverse events include nausea, dyspepsia, heartburn, abdominal pain, skin rash, pruritus, dyspnea, rhinitis, and influenza-like symptoms. These are usually transient and self-limiting. Report any concerning side effects immediately to your doctor. Drowsiness and dizziness may occur; avoid operating machinery or driving until the effects are known. Alcohol consumption should be avoided due to potential additive sedative effects. Prior to commencing treatment, disclose any hepatic or renal impairment for appropriate dose adjustment. Similarly, inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.

Uses of Abrofast-M Tablet PR

Managing and preventing asthma; managing and preventing chronic obstructive pulmonary disease (COPD); treating bronchitis.

Major Benefits of Abrofast-M Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. The Abrofast-M Tablet PR can be administered with or without food; however, consistent timing is recommended.

Common Side effects of Abrofast-M Tablet PR:

• Vomiting
• Heartburn
• Stomach pain
• Rash
• Itching
• Hives
• Drowsiness
• Breathing problems
• Increased white blood cell count
• Nasal inflammation
• Flu-like symptoms
• Sinus infection
• Ear infection

How to use Abrofast-M Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidelines. The Abrofast-M Tablet PR can be administered with or without food; however, consistent timing is recommended.

How Abrofast-M Tablet PR works:

Abrofast-M PR tablets contain acebrophylline and montelukast, working synergistically to manage respiratory symptoms. Acebrophylline, a mucolytic agent, reduces mucus viscosity, facilitating expectoration. Montelukast, a leukotriene receptor antagonist, inhibits leukotriene activity, thereby diminishing airway and nasal inflammation, providing both asthma prophylaxis and allergy symptom relief.

What if you forget to take Abrofast-M Tablet PR :

Should you forget a dose of Abrofast-M Tablet PR, ingest it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.